Product
OxyContin
2 clinical trials
2 indications
Indication
Healthy Control ParticipantsIndication
Cancer PainClinical trial
A Phase 1b, Randomized 2-Part Single-Center Study to Evaluate the PK and Safety of Multiple Ascending Oral Doses of PF614 and the Food Effect and BA/BE of Single Oral Doses of PF614 Relative to OxyContin in Healthy Adult SubjectsStatus: Completed, Estimated PCD: 2022-03-21
Clinical trial
A Multicenter, Randomized, Phase IIa/IIb Clinical Trial of 3D1002 Combined With Oxycodone Hydrochloride Sustained-release Tablets in the Treatment of Patients With Moderate to Severe Cancer PainStatus: Not yet recruiting, Estimated PCD: 2025-06-01